Nutrition & Metabolism (Jun 2012)

Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai population

  • Insawang Tonkla,
  • Selmi Carlo,
  • Cha’on Ubon,
  • Pethlert Supattra,
  • Yongvanit Puangrat,
  • Areejitranusorn Premjai,
  • Boonsiri Patcharee,
  • Khampitak Tueanjit,
  • Tangrassameeprasert Roongpet,
  • Pinitsoontorn Chadamas,
  • Prasongwattana Vitoon,
  • Gershwin M,
  • Hammock Bruce D

DOI
https://doi.org/10.1186/1743-7075-9-50
Journal volume & issue
Vol. 9, no. 1
p. 50

Abstract

Read online

Abstract Background Epidemiology and animal models suggest that dietary monosodium glutamate (MSG) may contribute to the onset of obesity and the metabolic syndrome. Methods Families (n = 324) from a rural area of Thailand were selected and provided MSG as the sole source for the use in meal preparation for 10 days. Three hundred forty-nine subjects aged 35–55 years completed the study and were evaluated for energy and nutrient intake, physical activity, and tobacco smoking. The prevalence of overweight and obesity (BMI ≥ 25 kg/m2), insulin resistance (HOMA-IR >3), and the metabolic syndrome (ATP III criteria) were evaluated according to the daily MSG intake. Results The prevalence of the metabolic syndrome was significantly higher in the tertile with the highest MSG intake. Further, every 1 g increase in MSG intake significantly increased the risk of having the metabolic syndrome (odds ratio 1.14, 95% confidence interval-CI- 1.12 - 1.28) or being overweight (odds ratio 1.16, 95% CI 1.04 - 1.29), independent of the total energy intake and the level of physical activity. Conclusion Higher amounts of individual MSG consumption are associated with the risk of having the metabolic syndrome and being overweight independent of other major determinants.

Keywords